Oculis Holding AG SEC filings OCS
Oculis Holding AG has 138 filings in SEC EDGAR's recent list, going back to Nov 7, 2022. Its latest annual report, Form 20-F, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 8, 2025 | — |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2024 | — |
| EFFECT | Filing | May 31, 2023 | — |
| CORRESP | Letter to the SEC | May 30, 2023 | — |
| CORRESP | Letter to the SEC | May 30, 2023 | — |
| UPLOAD | Letter from the SEC | May 17, 2023 | — |
| DRS | Filing | May 10, 2023 | — |
| EFFECT | Filing | May 1, 2023 | — |
| CORRESP | Letter to the SEC | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 20, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2023 | — |
| CERT | Filing | Mar 2, 2023 | — |
| 8-A12B | Filing | Mar 1, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2023 | — |
| EFFECT | Filing | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Feb 2, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2023 | — |
| CORRESP | Letter to the SEC | Jan 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2022 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCS (Nasdaq), OCSAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1953530
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.